Skip Navigation LinksHome > August 2013 - Volume 122 - Issue 2, PART 2 > Cabergoline Therapy for Cushing Disease Throughout Pregnancy
Obstetrics & Gynecology:
doi: 10.1097/AOG.0b013e31829e398a
Case Report

Cabergoline Therapy for Cushing Disease Throughout Pregnancy

Woo, Irene MD; Ehsanipoor, Robert M. MD

Collapse Box

Abstract

BACKGROUND: Cushing disease during pregnancy is rare and is associated with significant maternal and fetal morbidity and mortality. Transsphenoidal pituitary surgery is the first-line therapy; however, in cases of failed surgery or in patients who are not surgical candidates, medical therapy has been used to control symptoms.

CASE: A 29-year-old woman with Cushing disease and a noncurative transsphenoidal pituitary surgery was successfully treated with cabergoline, a dopamine agonist. After approximately 1 year of therapy, she became pregnant. She was maintained on high-dose cabergoline throughout her pregnancy and had an uncomplicated antenatal course. She went into spontaneous labor at 38 weeks of gestation and delivered a healthy female neonate.

CONCLUSION: Cabergoline can be used to manage Cushing disease successfully during pregnancy with an opportunity for a favorable outcome.

© 2013 by The American College of Obstetricians and Gynecologists.

Login

Article Tools

Share